4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-007767
Chief Financial Officer sold 3,763 shares at an average $9.86 ($37,090)
- Chief Financial Officer acquired 61,235 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal Chief Financial Officer | 2022-03-01 | Grant or award | +61,235 | 216,937 | D | ||
| Koppikar Utpal Chief Financial Officer | 2022-03-01 | Sale | −2,272 | $9.86 | $22,393 | 214,665 | D |
| Koppikar Utpal Chief Financial Officer | 2022-03-01 | Sale | −1,491 | $9.86 | $14,697 | 213,174 | D |
| Derivatives | |||||||
| Koppikar Utpal Chief Financial Officer | 2022-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +115,107 | 115,107 | D | ||
| Open-market sales · 3,763 sh · avg $9.86 · $37,090 | |||||||
Loading xslF345X03/form4.xml…